Brad Stanfield: The Low-Dose Peptide I Take

ByLongevity Notes Editorial
🟢
Peer-Reviewed Research
B
Brad Stanfield

Video Summary · May 28, 2026

View Full Protocol →

Key Takeaways

  • Tezepatide, a combination of GLP-1 and GIP, shows benefits beyond weight loss, including cardiovascular and kidney health improvements.
  • Semaglutide (e.g., Ozempic) may improve joint health and cartilage regeneration independent of weight loss.
  • Consider low-dose peptides like Desapatite or Tezepatide for potential longevity benefits, even if you don’t have diabetes or obesity.
  • Monitor emerging research on GLP-1 medications for cancer progression and addiction management.

Supplements & Protocols Mentioned

  • Desapatite: 1.25 mg injected weekly.
  • Tezepatide: Combination of GLP-1 and GIP used off-label for potential health benefits.

Notable Quotes

“Semaglutide’s protective effect on cartilage in osteoarthritis is independent of weight loss, challenging the traditional belief that osteoarthritis improvement relies solely on weight reduction.”

Bottom Line

Consider exploring low-dose peptides like Tezepatide or Semaglutide for potential health benefits beyond weight loss, especially if you’re interested in cardiovascular, kidney, and joint health.

Explore supplements mentioned in this video

Shop on iHerb →

Explore More

Watch the Full Video

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

⚡ Research Insider Weekly

Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.

No spam. Unsubscribe anytime. Powered by Beehiiv.

From Our Research Network

Part of the Evidence-Based Research Network

Similar Posts